平阳霉素治疗儿童口腔颌面部血管瘤的疗效评价  

Pingyangmycin Therapy of Oral and Maxillofacial Hemangioma in Children

作　　者：刘伟弘[1] 张瑛[1] 葛艳[1] 张瑾良[1] 

机构地区：[1]上海交通大学医学院附属新华医院口腔科,上海200092

出　　处：《口腔颌面外科杂志》2006年第4期349-351,共3页Journal of Oral and Maxillofacial Surgery

摘　　要：目的:探讨使用平阳霉素在血管瘤增长期进行治疗对其转归的影响。方法:对27例口腔颌面部血管瘤,在增长期采用平阳霉素注射,并对病例资料进行回顾性分析。结果:所有病例在治疗结束后,瘤体均不同程度缩小或消失。治愈23例(85.2%),好转4例(14.8%),总有效率达100%。共随访12例,所有12例患儿2年后复查血管瘤消退,无复发。结论:口腔颌面部血管瘤的早期治疗,近期是安全、有效的,有利于该病的早日完全消退。Objective： To discuss the effect of Pingyangmycin on children＇s hemangioma during its period of rapid growth. Methods： 27 children with oral and maxillofacial hemangioma were reviewed, and all these children were treated with Pingyangmycin during the period of disease＇s rapid growth. Results： The cure rate was 85.2%（23 127）, the catabatic rate was 14.8%（4 127）, and the total efficiency rate was 100%. 12 cases were followed up, and lesion faded away and hadn＇t recurred in 2 years. Conclusion： Therapy with Pingyangmycin on oral and maxillofacial hemangioma is safe and efficient.

关 键 词：血管瘤 治疗 平阳霉素 

分 类 号：R739.81[医药卫生—肿瘤]